The United States Food and Drug Administration (USFDA) has completed inspection of J.B. Chemicals & Pharmaceuticals’ formulations manufacturing facility - T20 located at Panoli, Gujarat. The inspection was conducted from June 5, 2023 to June 9, 2023. At the end of the inspection, the facility received ‘No Observations’ and thus NO Form 483 was issued.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
